Pfizer Inc. (NYSE:PFE), and Microsoft Corporation (NASDAQ:MSFT) are taking their household names and turning them into the collective Partnership for American Innovation (PAI). The U.S. Senate is currently looking at legislation that would limit the powers of patent assertion entities, derogatorily referred to as patent trolls, but at the same time making software and biotechnology innovations unpatentable. Pfizer Inc.(NYSE:PFE) shares after opening at $32.43 moved to $32.49 on last trade day and at the end of the day closed at $32.40. Company price to sales ratio in past twelve months was calculated as 4.02 and price to cash ratio as 6.39. Pfizer Inc. (NYSE:PFE) showed a positive weekly performance of 0.93%.
Boston Scientific Corporation (NYSE:BSX) Director Ernest Mario unloaded 10,000 shares of Boston Scientific stock in a transaction dated Tuesday, April 1st. The shares were sold at an average price of $13.55, for a total transaction of $135,500.00. Following the sale, the director now directly owns 327,855 shares of the company’s stock, valued at approximately $4,442,435. Boston Scientific Corporation (NYSE:BSX) shares advanced 0.58% in last trading session and ended the day on $13.77. BSX return on equity ratio is recorded as -1.80% and its return on assets is -0.70%. Boston Scientific Corporation (NYSE:BSX) yearly performance is 73.86%.
Shares of Response Genetics, Inc. (NASDAQ:RGDX) jumped 18 percent on Thursday after the cancer diagnostic test company signed agreements with six additional health plans and two large health care groups.The East Los Angeles company’s testing services help determine a patient’s response to certain cancer treatments. Response Genetics said the deals were with Blue Cross/Blue Shield plans in Arizona, Iowa, South Dakota, Pennsylvania, Delaware and West Virginia. Response Genetics also signed agreements with an unnamed independent physician association covering two states in the Northwestern United States and a commercial health plan covering two states in the Northeastern United States. Response Genetics, Inc. (NASDAQ:RGDX) shares moved up 18.33% in last trading session and was closed at $1.42, while trading in range of $ 1.34 – 1.56. Response Genetics, Inc. (NASDAQ:RGDX) year to date (YTD) performance is 22.41%.
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) continued in green a day later, after the company announced that the U.S. Supreme court has accepted to hear its appeal against Natco Pharma Ltd. (NTCPH) over patent revival that would enable the company to protect its drug, Copaxone multiple-sclerosis from generic competition. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) weekly performance is 10.01%. On last trading day company shares ended up $54.06. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) distance from 50-day simple moving average (SMA50) is 14.05%. Analysts mean target price for the company is $50.60.